Trinity Biotech Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio34.16
Forward P/E24.2024.2024.2028.6010.03
P/S Ratio0.250.290.600.370.78
P/B Ratio-0.44-0.68-17.34-93.70-35.89
Price/FCF2.623.88
Price/OCF2.263.35
PEG Ratio1.611.611.611.910.67
Enterprise Value Ratios
EV/Revenue1.731.221.601.231.56
EV/EBITDA10.917.41
EV/EBIT15.518.65
EV/FCF8.767.77
Profitability & Returns
Return on Equity (ROE)-4.82%
Return on Assets (ROA)-0.11%-0.13%-0.08%0.03%0.09%
Return on Invested Capital (ROIC)-0.27%-0.31%-0.20%0.09%0.22%
Return on Capital Employed (ROCE)-0.19%-0.36%-0.18%0.35%0.18%
Leverage & Solvency Ratios
Debt/Equity-2.86-2.81-33.18-310.84-47.02
Debt/EBITDA10.804.85
Debt/FCF8.685.08
Liquidity Ratios
Current Ratio1.282.602.690.723.08
Quick Ratio0.621.111.280.411.92
Efficiency Ratios
Asset Turnover0.760.750.590.650.78
Inventory Turnover2.041.761.751.611.72
Yield & Distribution Ratios
Earnings Yield-2.07%-1.47%-1.09%0.03%-0.08%
FCF Yield-0.30%-0.75%-0.05%0.38%0.26%
Buyback Yield-1.35%-0.13%-0.61%
Total Return-1.35%-0.13%-0.61%